TBPH vs BIIB: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Biogen Inc in 2026
TBPH
Theravance Biopharma Inc
$17.23
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | TBPH | BIIB | Winner |
|---|---|---|---|
| Market Cap | $887.22M | $26.03B | BIIB |
| P/E Ratio | 8.36 | 20.04 | TBPH |
| EPS (TTM) | $2.06 | $8.85 | BIIB |
| Revenue Growth | 1.4% | -0.1% | TBPH |
| Gross Margin | 65.2% | 78.9% | BIIB |
Analyze TBPH
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or BIIB a better investment?
Comparing TBPH and BIIB: Theravance Biopharma Inc has a market cap of $887.22M while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and BIIB?
TBPH (Theravance Biopharma Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or BIIB?
Based on P/E ratios, TBPH trades at a lower multiple (8.4x vs 20.0x).
Which is growing faster: TBPH or BIIB?
TBPH has higher revenue growth at 1.4% vs -0.1% for BIIB.
Which company is more profitable: TBPH or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 65.2% for TBPH.
Which is the larger company: TBPH or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $887.22M for TBPH.
Should I buy TBPH or BIIB in 2026?
Both TBPH and BIIB have investment merit. TBPH trades at $17.23 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and BIIB stock?
Key differences: Market Cap ($887.22M vs $26.03B), P/E Ratio (8.4x vs 20.0x), Revenue Growth (1.4% vs -0.1%), Gross Margin (65.2% vs 78.9%).